Microbial fuel cells
-
DATABASE (22)
-
ARTICLES (74)
TreeFrog Therapeutics’ C-Stem technology mass-produces high-quality pluripotent stem cells in a 3D environment that mimics the way cells grow in the human body.
TreeFrog Therapeutics’ C-Stem technology mass-produces high-quality pluripotent stem cells in a 3D environment that mimics the way cells grow in the human body.
Co-founder of KODI
Nofriza Nindiyasari is a software engineer with over 15 years of experience in technical roles. She has a bachelor's degree in Information Technology from Universitas Mpu Tantular and a master's in Education from UHAMKA, Indonesia.She has worked for a variety of companies, from minor engineering and tech companies to the state-owned gas fuel manufacturer. She is now a co-founder of KODI, a fintech digital platform to help cooperative businesses to automate and manage their finances more transparently.
Nofriza Nindiyasari is a software engineer with over 15 years of experience in technical roles. She has a bachelor's degree in Information Technology from Universitas Mpu Tantular and a master's in Education from UHAMKA, Indonesia.She has worked for a variety of companies, from minor engineering and tech companies to the state-owned gas fuel manufacturer. She is now a co-founder of KODI, a fintech digital platform to help cooperative businesses to automate and manage their finances more transparently.
B'Smart to speed up adoption of AI-data technology in traditional sectors like transport and logistics, boosting profitability with IoT for fleet management.
B'Smart to speed up adoption of AI-data technology in traditional sectors like transport and logistics, boosting profitability with IoT for fleet management.
The Alexa Fund provides up to $200 million in venture capital funding to fuel voice technology innovation. It is focused on how voice technology can improve customers’ lives, from early-stage pre-revenue companies to established brands. Areas of particular interest include: hardware products that would benefit from the Alexa Voice Service; skills that deliver new abilities to Alexa-enabled devices through the Alexa Skills Kit; and new contributions to the science behind voice technology, including text to speech, natural language understanding, automatic speech recognition, artificial intelligence and hardware component design.
The Alexa Fund provides up to $200 million in venture capital funding to fuel voice technology innovation. It is focused on how voice technology can improve customers’ lives, from early-stage pre-revenue companies to established brands. Areas of particular interest include: hardware products that would benefit from the Alexa Voice Service; skills that deliver new abilities to Alexa-enabled devices through the Alexa Skills Kit; and new contributions to the science behind voice technology, including text to speech, natural language understanding, automatic speech recognition, artificial intelligence and hardware component design.
Founder of TreeFrog Therapeutics
Maxime Feyeux is President, CSO and co-founder of TreeFrog Therapeutics whose proprietory C-Stem technology mass-produces high-quality pluripotent stem cells in a 3D environment. Prior to founding TreeFrog in 2018, Feyeux worked as a maturation engineer at Aquitaine Science Transfert and completed a post-doctoral degree at Bordeaux’s Institut des Maladies Neurodégénératives. He also has a post-doctoral degree from the University of Geneva and completed his PhD in neurobiology and neurosciences at the Université d’Evry-Val d’Essone.
Maxime Feyeux is President, CSO and co-founder of TreeFrog Therapeutics whose proprietory C-Stem technology mass-produces high-quality pluripotent stem cells in a 3D environment. Prior to founding TreeFrog in 2018, Feyeux worked as a maturation engineer at Aquitaine Science Transfert and completed a post-doctoral degree at Bordeaux’s Institut des Maladies Neurodégénératives. He also has a post-doctoral degree from the University of Geneva and completed his PhD in neurobiology and neurosciences at the Université d’Evry-Val d’Essone.
Co-founder, CEO of Meatable
Krijn De Nood is the Dutch co-founder and CEO at cell-based meat startup Meatable, the first to claim a highly scalable culture technology with the use of pluripotent stem cells, where he has worked since 2018. He previously worked at McKinsey for six-and-a-half years in Amsterdam, New York and in Kenya. Prior to that, he worked as an equity derivatives trader at derivative trading company All Options after a short stint at Barclays Capital.De Nood holds two first degrees from the University of Amsterdam, in philosophy and in economics and finance.
Krijn De Nood is the Dutch co-founder and CEO at cell-based meat startup Meatable, the first to claim a highly scalable culture technology with the use of pluripotent stem cells, where he has worked since 2018. He previously worked at McKinsey for six-and-a-half years in Amsterdam, New York and in Kenya. Prior to that, he worked as an equity derivatives trader at derivative trading company All Options after a short stint at Barclays Capital.De Nood holds two first degrees from the University of Amsterdam, in philosophy and in economics and finance.
Founder of TreeFrog Therapeutics
Kévin Alessandri is CEO, CTO and co-founder of TreeFrog Therapeutics, whose proprietory C-Stem technology mass-produces high-quality pluripotent stem cells in a 3D environment. Prior to founding TreeFrog in 2018, Alessandri spent two years as a post-doctoral fellow at Bordeaux’s Institut d’Optique. During 2014 and 2015, he completed a post-doctorate at the University of Geneva, focused on developing 3D printed microfluidics systems to build 3D cell culture vessels for stem cell applications. From 2008 to 2013 he completed a PhD on cellular capsules technology and applications at the Institut Curie in Paris.
Kévin Alessandri is CEO, CTO and co-founder of TreeFrog Therapeutics, whose proprietory C-Stem technology mass-produces high-quality pluripotent stem cells in a 3D environment. Prior to founding TreeFrog in 2018, Alessandri spent two years as a post-doctoral fellow at Bordeaux’s Institut d’Optique. During 2014 and 2015, he completed a post-doctorate at the University of Geneva, focused on developing 3D printed microfluidics systems to build 3D cell culture vessels for stem cell applications. From 2008 to 2013 he completed a PhD on cellular capsules technology and applications at the Institut Curie in Paris.
Founder of TreeFrog Therapeutics
Jean-Luc Treillou is co-founder of TreeFrog Therapeutics, whose proprietory C-Stem technology mass-produces high-quality pluripotent stem cells in a 3D environment. Since January 2019, he has also acted as an advisor and member of the strategic committee of IT security company Eshard. Prior to co-founding TreeFrog, Treillou founded YSOPIA Bioscience in 2011, where he was CEO until he left in 2021, and Chairman of the Board from 2018. Between 2009 and 2013 he held the posts of General Manager and Chairman of the Board at French R&D company Nutrionix.
Jean-Luc Treillou is co-founder of TreeFrog Therapeutics, whose proprietory C-Stem technology mass-produces high-quality pluripotent stem cells in a 3D environment. Since January 2019, he has also acted as an advisor and member of the strategic committee of IT security company Eshard. Prior to co-founding TreeFrog, Treillou founded YSOPIA Bioscience in 2011, where he was CEO until he left in 2021, and Chairman of the Board from 2018. Between 2009 and 2013 he held the posts of General Manager and Chairman of the Board at French R&D company Nutrionix.
New York-based Humboldt Fund invests in startups with the potential to solve critical issues of our time across the areas of food production, healthcare, energy, and construction and manufacturing materials. It currently has 14 companies in its portfolio. Its most recent investments include in the March 2021 $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech, and in the February 2021 $16m seed round of US biotech Cellino Biotech.
New York-based Humboldt Fund invests in startups with the potential to solve critical issues of our time across the areas of food production, healthcare, energy, and construction and manufacturing materials. It currently has 14 companies in its portfolio. Its most recent investments include in the March 2021 $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech, and in the February 2021 $16m seed round of US biotech Cellino Biotech.
Meatable’s proprietary OPTi-OX technology is a pioneer in enabling scalable cell-based production of entire meat joints, 100% animal-free, starting with pork and beef.
Meatable’s proprietary OPTi-OX technology is a pioneer in enabling scalable cell-based production of entire meat joints, 100% animal-free, starting with pork and beef.
Jeffrey Leiden is a physician and scientist of more than 40 years, who is currently the executive chairman of US-based multinational biotech company Vertex Pharmaceuticals. Leiden is also the chairman of Casana, a remote healthcare platform and the chairman of Tmunity, a biotech dedicated to T-cell research. In March 2021, he participated as an angel investor in the $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech.
Jeffrey Leiden is a physician and scientist of more than 40 years, who is currently the executive chairman of US-based multinational biotech company Vertex Pharmaceuticals. Leiden is also the chairman of Casana, a remote healthcare platform and the chairman of Tmunity, a biotech dedicated to T-cell research. In March 2021, he participated as an angel investor in the $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech.
World's first renewable energy plug-in electric system for refrigerated trucks enables cold-chain operation in non-diesel mode – reducing emissions, fuel consumption and maintenance costs.
World's first renewable energy plug-in electric system for refrigerated trucks enables cold-chain operation in non-diesel mode – reducing emissions, fuel consumption and maintenance costs.
Founded in 2016, Berlin-based investor BlueYard invests in startups aiming to tackle the planet’s greatest challenges. It typically makes $1m–3m as an initial investment and has no geographical bias. Its most recent investments include in the March 2021 $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech and in the February 2021 $4m seed round of Next Matter, a German Open Source automation tool for operations teams.
Founded in 2016, Berlin-based investor BlueYard invests in startups aiming to tackle the planet’s greatest challenges. It typically makes $1m–3m as an initial investment and has no geographical bias. Its most recent investments include in the March 2021 $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech and in the February 2021 $4m seed round of Next Matter, a German Open Source automation tool for operations teams.
Founded in 2011, London-based Agronomics Limited’s principal investing interest is in environmentally-friendly alternatives to the traditional production of meat, wherever they may be located. There are currently 17 companies in its portfolio, all of them in the cellular-based or plant-based protein category and sustainable food production.Its most recent declared investments have been in the March 2021 $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech, and in the December 2020 undisclosed pre-seed round of Chinese cellular foodtech CellX.
Founded in 2011, London-based Agronomics Limited’s principal investing interest is in environmentally-friendly alternatives to the traditional production of meat, wherever they may be located. There are currently 17 companies in its portfolio, all of them in the cellular-based or plant-based protein category and sustainable food production.Its most recent declared investments have been in the March 2021 $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech, and in the December 2020 undisclosed pre-seed round of Chinese cellular foodtech CellX.
Rick Klausner is an award-winning scientist, former executive director of the Bill & Melinda Gates Foundation and an entrepreneur. Cell and molecular biologist Klausner was also director of the US National Cancer Institute from 1999-2001 and currently serves as CEO at biotech Lyell Immunopharma working with cell-based technology. He has also co-founded three US healthcare startups to date, Juno Therapeutics in 2013, MindStrong Health in 2014 and GRAIL in 2015. In 2021, he participated as an investor in the $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech.
Rick Klausner is an award-winning scientist, former executive director of the Bill & Melinda Gates Foundation and an entrepreneur. Cell and molecular biologist Klausner was also director of the US National Cancer Institute from 1999-2001 and currently serves as CEO at biotech Lyell Immunopharma working with cell-based technology. He has also co-founded three US healthcare startups to date, Juno Therapeutics in 2013, MindStrong Health in 2014 and GRAIL in 2015. In 2021, he participated as an investor in the $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech.
- 1
- 2
Bygen: Turning waste into activated carbon
Australian startup Bygen is offering agribusinesses more reasons to upcycle waste sustainably into a lucrative product with its eco-friendly process to make activated carbon
Benergy: A new app to track gut health with smart data
The Benergy app allows results to be shared with doctors to facilitate diagnosis and includes swap tests
Investing in Indonesia: The fintech companies driving a new influx of capital
With 66% of Indonesians not owning a bank account, fintech startups have come up with myriad innovative products to entice a new generation of retail investors
Dipole Tech: Using blockchain to democratize access to renewable energy in Asia
Having established key markets in the Philippines and Thailand, China’s Dipole Tech is next gaining ground at home for its energy trading app
Xurya: Pioneering solar power as a service in Indonesia with a leasing model
Targeting corporate customers without need for any upfront payment, two-year-old Xurya has already attracted major clients, and investment from Clime Capital’s impact investment fund SEACEF
Dao Foods unfazed by China tech crackdown, says alternative proteins aligned with state goals
Impact investor Dao Foods expects government support for alternative proteins to come, as it announces second batch of startups, diversifying into fermentation and cell-based proteins
Renewable energy crowdfunding platform Fundeen eyes 2019 profit amid sector boom
The young Spanish startup is eyeing projects worth €220 million by 2023, while cutting CO2 emissions equivalent to 1.3 million Madrid-New York flights
Clarity AI uses machine learning and data analytics to effectively assess and score environmental, social and governance performance of companies and investment portfolios
Qairos Energies: Mass producing green hydrogen from industrial hemp
The French startup is seeking a €19m Series B round to produce industrial quantities of green hydrogen and is planning a “circular economy” partnership with local farmers
String Bio: Asia's first startup to harness methane gas for protein production
Using bacteria to turn the harmful greenhouse gas into a purer form of protein, String Bio is raising Series B funding to scale production
Good Startup: Alt-protein products can be better than real meat
The investor of Eat Just, Ripple Foods and more expects its portfolio companies will exit in the next four to six years, mostly through acquisition
Jungle.ai: Tapping data and AI to prevent outages and breakdowns
Forewarned is forearmed. Performance predictions by Jungle.ai can help save billions of dollars and hours of frustration caused by sudden power failures
Place to Plug: Symbiosis in scaling with the electric vehicle sector
Launched commercially just five months ago, EV-charging infrastructure platform Place to Plug has already attracted attention from investors in Silicon Valley and Asia
Portugal oceantech II: Single-minded efforts to build an ecosystem of international reference
With dedicated accelerators and investment programs, supported by the EU’s vote of confidence, Portugal appears on track to lead in oceantech
DORM: New-generation housing for Indonesia’s tech-savvy, community-driven students
Combining online features with offline services, DORM goes way beyond what the market typically offers in student accommodation
Sorry, we couldn’t find any matches for“Microbial fuel cells”.
POPULAR DATABASE
